Loading...
Arcellx, Inc.
ACLX•NASDAQ
Healthcare
Biotechnology
$71.31
$1.04(1.48%)
Arcellx, Inc. (ACLX) Financial Performance & Income Statement Overview
Review Arcellx, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-2.16%
↓ 2.16%
Operating Income Growth
-53.06%
↓ 53.06%
Net Income Growth
-51.86%
↓ 51.86%
Operating Cash Flow Growth
-140.21%
↓ 140.21%
Operating Margin
-248.22%
↓ 248.22%
Gross Margin
98.39%
↑ 98.39%
Net Profit Margin
-211.46%
↓ 211.46%
ROE
-35.27%
↓ 35.27%
ROIC
-35.60%
↓ 35.60%
Arcellx, Inc. (ACLX) Income Statement & Financial Overview
Review Arcellx, Inc.'s (ACLX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $15.27M | $26.03M | $27.38M | $39.26M |
| Cost of Revenue | $0.00 | $0.00 | $1.24M | $826000.00 |
| Gross Profit | $15.27M | $26.03M | $26.14M | $38.43M |
| Gross Profit Ratio | $1.00 | $1.00 | $0.95 | $0.98 |
| R&D Expenses | $44.65M | $39.17M | $40.95M | $32.32M |
| SG&A Expenses | $23.77M | $20.47M | $20.18M | $21.92M |
| Operating Expenses | $68.42M | $59.65M | $61.14M | $54.24M |
| Total Costs & Expenses | $68.42M | $59.65M | $62.38M | $55.07M |
| Interest Income | $7.58M | $8.09M | $8.45M | $9.20M |
| Interest Expense | $7000.00 | $114000.00 | $321000.00 | $588000.00 |
| Depreciation & Amortization | $1.79M | $1.33M | $1.24M | $826000.00 |
| EBITDA | -$43.78M | -$24.20M | -$25.30M | -$5.78M |
| EBITDA Ratio | -$2.87 | -$0.93 | -$1.23 | -$0.38 |
| Operating Income | -$53.15M | -$33.62M | -$34.99M | -$15.81M |
| Operating Income Ratio | -$3.48 | -$1.29 | -$1.28 | -$0.40 |
| Other Income/Expenses (Net) | $7.58M | $7.97M | $8.13M | $8.61M |
| Income Before Tax | -$45.58M | -$25.64M | -$26.86M | -$7.20M |
| Income Before Tax Ratio | -$2.99 | -$0.99 | -$0.98 | -$0.18 |
| Income Tax Expense | $1.50M | $223000.00 | $341000.00 | $782724.00 |
| Net Income | -$47.08M | -$25.87M | -$27.20M | -$7.20M |
| Net Income Ratio | -$3.08 | -$0.99 | -$0.99 | -$0.18 |
| EPS | -$0.88 | -$0.48 | -$0.51 | -$0.14 |
| Diluted EPS | -$0.88 | -$0.48 | -$0.51 | -$0.14 |
| Weighted Avg Shares Outstanding | $53.69M | $53.82M | $53.52M | $52.76M |
| Weighted Avg Shares Outstanding (Diluted) | $53.69M | $53.82M | $53.52M | $52.76M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan